Loading…
Preoperative Typing of Thyroid and Parathyroid Tumors with a Combined Molecular Classifier
In previous studies, we described a method for detecting and typing malignant tumors of the thyroid gland in fine-needle aspiration biopsy samples via analysis of a molecular marker panel (normalized mRNA level; normalized microRNA-146b, -221, and -375 levels; mitochondrial-to-nuclear DNA ratio; and...
Saved in:
Published in: | Cancers 2021-01, Vol.13 (2), p.237 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In previous studies, we described a method for detecting and typing malignant tumors of the thyroid gland in fine-needle aspiration biopsy samples via analysis of a molecular marker panel (normalized
mRNA level; normalized microRNA-146b, -221, and -375 levels; mitochondrial-to-nuclear DNA ratio; and
mutation) in cytological preparations by quantitative PCR. In the present study, we aimed to estimate the specificity of the typing of different thyroid tumors by the proposed method. Fine-needle aspiration cytological preparations from 278 patients were used. The histological diagnosis was known for each sample. The positive and negative predictive values of the method assessed in this study were, respectively, 100% and 98% for papillary thyroid carcinoma (
= 63), 100% and 100% for medullary thyroid carcinoma (
= 19), 43.5% and 98% for follicular carcinoma (
= 15), and 86% and 100% for Hürthle cell carcinoma (
= 6). Thus, we demonstrate that the diagnostic panel, including the analysis of microRNA expression, mRNA expression, the
mutation, and the mitochondrial-to-nuclear DNA ratio, allows the highly accurate identification of papillary thyroid carcinoma, medullary thyroid carcinoma, and Hürthle cell carcinoma but not malignant follicular tumors (positive predictive value was below 50%). |
---|---|
ISSN: | 2072-6694 2072-6694 |
DOI: | 10.3390/cancers13020237 |